What is the ICD-10 code for increased arousal in an adult patient with a history of mental health issues starting sertraline (Zoloft)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Coding for Increased Arousal When Starting Sertraline (Zoloft)

The appropriate ICD-10 code for increased arousal or agitation when initiating sertraline is R45.1 (Restlessness and agitation), which captures the acute behavioral symptom, while the underlying mental health condition requiring sertraline treatment should be coded separately as the primary diagnosis.

Primary Coding Approach

  • R45.1 (Restlessness and agitation) is the most specific code for the acute symptom of increased arousal or agitation that occurs as an adverse effect when starting SSRIs like sertraline 1, 2.

  • The underlying psychiatric diagnosis (e.g., F32.x for major depressive disorder, F41.x for anxiety disorders, F43.1 for PTSD) should be listed as the primary diagnosis, with R45.1 as a secondary code to document the treatment-related symptom 3.

Clinical Context for This Coding Scenario

  • Increased anxiety, agitation, and arousal are recognized initial adverse effects of SSRIs that commonly occur during treatment initiation or dose escalation, particularly in patients with underlying anxiety disorders 1.

  • This activation syndrome typically manifests within the first few weeks of SSRI treatment and can include symptoms of restlessness, agitation, increased arousal, insomnia, and akathisia 1, 2.

  • Sertraline-induced agitation has been documented in clinical trials and case reports, with one case describing acute agitation, diaphoresis, and altered mental status in the setting of rapid sertraline titration 2.

Alternative or Additional Codes to Consider

  • F19.99 (Other psychoactive substance use, unspecified with unspecified psychoactive substance-induced disorder) may be appropriate if the increased arousal represents a more severe medication-induced psychiatric syndrome, though this is less commonly used for routine SSRI activation 2.

  • G25.71 (Drug induced akathisia) should be used if the increased arousal specifically manifests as motor restlessness and an inability to sit still, which can occur with SSRIs 1.

  • F51.02 (Adjustment insomnia) may be added if the increased arousal is primarily manifesting as sleep disturbance, as sertraline is activating and commonly causes insomnia when initiated 1, 4.

Important Coding Caveats

  • Do not use codes for serotonin syndrome (G25.79 or T43.221A) unless the patient meets clinical criteria for true serotonin syndrome with the classic triad of neuromuscular excitation, autonomic instability, and altered mental status 2.

  • Avoid using codes for substance-induced mood disorder unless the activation syndrome has progressed to a full manic or hypomanic episode, which would warrant F19.14 (Other psychoactive substance abuse with psychoactive substance-induced mood disorder) 5.

  • The code R45.1 is preferable to vague codes like R45.89 (Other symptoms and signs involving emotional state) because it specifically captures the agitation component 1.

Related Questions

What is the best antidepressant for a 61-year-old patient with primary depressive symptoms and comorbid anxiety, who is naive to psych (psychiatric) meds, such as selective serotonin reuptake inhibitors (SSRIs) like sertraline (Zoloft)?
What are the next steps for a 25-year-old female with insomnia, anxiety, and depression who is taking sertraline (Zoloft) and has not responded to hydroxyzine HCl 25mg for sleep?
What is the recommended medication management for a 55-year-old male patient with anxiety, depression, and low energy?
Are there concerns with continuing sertraline (selective serotonin reuptake inhibitor) 100mg and duloxetine (serotonin-norepinephrine reuptake inhibitor) 30mg in an elderly patient?
Can increased doses of Zoloft (sertraline) cause insomnia?
What is the approach for a patient seeking emergency contraception in an outpatient clinic office?
What is the dosing regimen for Aztreonam (aztreonam)/avibactam in treating bacterial infections?
What is the recommended dosage and treatment approach for Metoclopramide (metoclopramide) in a child with gastroesophageal reflux disease (GERD)?
What is the management approach for a postmenopausal woman with new vaginal bleeding while on enoxaparin (low molecular weight heparin) for severe deep vein thrombosis (DVT)?
To whom should a patient with toenail fungus, potentially with underlying health conditions such as diabetes or liver disease, be referred for proper evaluation and treatment?
What is the recommended evaluation and management for a 17-year-old female with a intermittent bump on the dorsal aspect of her foot?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.